Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

High-Volume Injection with and without Corticosteroid in Chronic Midportion Achilles Tendinopathy

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Physical activity during pregnancy and intelligence in sons; A cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The effect of two exercise modalities on skeletal muscle capillary ultrastructure in individuals with type 2 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Effect of endurance versus resistance training on local muscle and systemic inflammation and oxidative stress in COPD

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Response to Millet and Brocherie

    Research output: Contribution to journalComment/debateResearchpeer-review

  1. Validity and reliability of an ultrasound measurement of the free length of the Achilles tendon

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Kronisk achillessene tendinopati

    Research output: Contribution to journalJournal articleCommunication

  3. Extracorporeal shock wave therapy in chronic Achilles tendinopathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Tendon collagen synthesis declines with immobilization in elderly humans: no effect of anti-inflammatory medication

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: High volume injection (HVI) shows promising results in the treatment of chronic midportion Achilles tendinopathy (AT). HVI consists of a large volume of saline with a small amount of corticosteroid and local anesthetic.

OBJECTIVE: To determine the effect of corticosteroid in HVI in AT.

METHODS: A total of 28 men (18-59 years) with chronic (>3 months) AT were included in a double-blinded RCT and followed for 24 weeks. All performed eccentric training and randomized to either (a) HVI injection with corticosteroid or (b) HVI injection without corticosteroid. Outcomes included self-reported function (VISA-A score) and pain (VAS score) and ultrasound imaging (tendon thickness, Doppler flow).

RESULTS: VISA-A and VAS score improved in both groups at all time-points (P < 0.05). VISA-A improvement was significantly greater in HVI with corticosteroid (mean ± SEM; 6-weeks = 31 ± 3 points; 12-weeks = 32 ± 5 points) vs HVI without corticosteroid (6 weeks = 14 ± 3; 12-weeks = 17 ± 3) at 6 and 12 weeks (P < 0.05), but not at 24 weeks. Decrease in VAS scores was significantly greater in HVI with corticosteroid (6 weeks = 55 ± 3 mm; 12 weeks = 53 ± 5 mm) vs HVI without corticosteroid (6 weeks = 16 ± 3 mm; 12 weeks = 25 ± 5 mm) at 6 and 12 weeks (P < 0.05) but not at 24 weeks. Tendon thickness decreased significantly in both groups at all time-points (P < 0.05), but more in the HVI with corticosteroid vs HVI without corticosteroid at 6 and 12 weeks (P < 0.05) but not at 24 weeks.

CONCLUSION: High volume injection with or without corticosteroid in combination with eccentric training seems effective in AT. HVI with corticosteroid showed a better short-term improvement than HVI without corticosteroid indicating a short-term effect of corticosteroid in HVI treatment of AT.

Original languageEnglish
JournalScandinavian journal of medicine & science in sports
Volume29
Issue number8
Pages (from-to)1223-1231
Number of pages9
ISSN0905-7188
DOIs
Publication statusPublished - Aug 2019

Bibliographical note

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

    Research areas

  • color Doppler, eccentric training, tendon overuse injury, ultrasound imaging, VISA-A score

ID: 57091163